Jardiance Declared Best International Pharmaceutical Product 2018

Jardiance Declared Best International Pharmaceutical Product 2018 Boehringer Ingelheim’s sodium-glucose co-transporter 2 (SGLT-2) inhibitor, Jardiance (empagliflozin), has been announced winner of the 2018 Prix Galien International Award in the category “Best...

Maternal mortality – Fact Sheet

Maternal mortality - Fact SheetMSD for Mothers     Global statistics1 • Every day, approximately 830 women die from preventable causes related to pregnancy and childbirth. • 99% of all maternal deaths occur in developing countries. • Maternal mortality is...

Empagliflozin proven to improve clinical outcomes in real world practice across a broad spectrum of cardiovascular risk

The most recent 2018 treatment recommendations from the American Diabetes Association are that, after considering drug specific and patient factors, treatment for people with atherosclerotic cardiovascular disease (ASCVD) should begin with lifestyle management and metformin and subsequently incorporate an agent proven to reduce major adverse cardiovascular events and/or cardiovascular mortality.


It is estimated that three-and-a-half million South Africans (about 6% of the population), reported in 2012, suffer from diabetes and there are many more who remain undiagnosed.


Muscle strain or spasm caused by injury, sport or work related accidents can be effectively relieved using South Africa’s most prescribed muscle relaxant brand, Norflex®.

NRF B-COMPLEX FIZZY – instant energy boost

With modern day stress and fast pace living, it is difficult to maintain high levels of energy necessary to keep going all day long.  NRF B-Complex fizzy is a delicious, cranberry flavoured effervescent tablet with antioxidants which helps to boost energy effectively.  A tablet should be taken daily in half a glass of water. 

New Novartis South Africa CEO to continue building on partnerships

Novartis South Africa aims to continue building on local partnerships and health development initiatives, following the appointment of Dr. Mahomed (Mo) Kadwa as the company’s new Chief Executive Officer: Novartis South Africa and Head: Southern African Countries.

Wildcard SSL